ERP29

Endoplasmic reticulum resident protein 29 · P30040 · ERP29 on Sugi Atlas →

0 patent compounds predicted against ERP29, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to ERP29 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Effects of Liraglutide on ER Stress in Obese Patients With Type 2 Diabetes PHASE4UNKNOWN
Targeting Endoplasmic Reticulum Stress in Human Hypertension PHASE1/PHASE2RECRUITING
Ambroxol Therapy for Patients With Type 1 Gaucher Disease and Suboptimal Response to Enzyme Replacement Therapy PHASE2COMPLETED
Pembrolizumab Plus Enfortumab Vedotin in Collecting Duct and Renal Medullary Carcinoma PHASE2RECRUITING
Megestrol Acetate or Levonorgestrel-Releasing Intrauterine System in Treating Patients With Atypical Endometrial Hyperplasia or Endometrial Cancer PHASE2WITHDRAWN
Modulate Cellular Stress in the Immune Cells to Reduce Rate of Symptomatic Viral Infection PHASE2COMPLETED
CHED - Congenital Hereditary Endothelial Dystrophy: New Paradigm Shift in Therapy Using Topical Eye Drops PHASE2UNKNOWN
Evaluation of the Possible Safety and Efficacy of Dapagliflozin in the Prophylaxis of Doxorubicin-Induced Cardiotoxicity PHASE2RECRUITING
Ataxia-telangiectasia: Treating Mitochondrial Dysfunction With a Novel Form of Anaplerosis PHASE2COMPLETED
Phase I Study of Novel Estrogen Receptor(ER) a36 Modifier Icaritin in Advanced Breast Cancer Patients PHASE1UNKNOWN
A Phase Ib Study to Assess Safety and Efficacy of Oral Icaritin in Advanced Solid Tumors PHASE1COMPLETED
A Phase I Study of Pyrimethamine in Patients With GM2 Gangliosidosis PHASE1WITHDRAWN
PBA Use for Treatment of ATF6-/- Patients EARLY_PHASE1SUSPENDED
The Study of Quadruple Therapy Quercetin, Zinc, Metformin, and EGCG as Adjuvant Therapy for Early, Metastatic Breast Cancer and Triple-negative Breast Cancer, a Novel Mechanism EARLY_PHASE1UNKNOWN
Quantification of GADD34 Expression in RA nanCOMPLETED
Immunological Profile and Clinical Characteristics of Children Diagnosed With Chronic Granulomatous Disease nanUNKNOWN
MERC Proteins in Saliva and GCF in Periodontal Disease (ELISA Study) nanCOMPLETED
Establishment of Human Cellular Disease Models for Wilson Disease nanCOMPLETED
Tracking Neurodegeneration in Early Wolfram Syndrome nanCOMPLETED
Wolfram Syndrome and WFS1-related Disorders International Registry and Clinical Study nanRECRUITING
Fatty Acids Lipidome and Oxidative Stress in Liver Transplantation nanUNKNOWN
sCD163 in ALS Patients nanCOMPLETED
Exercise on Expression of Heat Shock Protein 70 in Arterial Risk nanCOMPLETED
The Role of DNA and RNA in NGS Analyses for Advaced Stage NSCLC Patients nanRECRUITING
Mitochondrial Membrane Protein Neurodegeneration (MPAN) nanCOMPLETED
Predicting Pancreatic Necrosis Using mitDNA nanUNKNOWN
Preliminary Study for Identification of Calcium-Binding Proteins in the Serum in Various Metabolic Bone Disorders nanUNKNOWN
Endoplasmic Reticulum Stress and Resistance to Treatments in Ph-negative Myeloproliferative Neoplasms nanCOMPLETED
Effect of Protein on Endoplasmic Reticulum Stress nanNOT_YET_RECRUITING
Hydroxychloroquin (HCQ) in chILD of Genetic Defect nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a ERP29 binder may also engage these)

ProteinNameSimilarity
P52555 1.000 P52555 →
P81623 1.000 P81623 →
P81628 1.000 P81628 →
P57759 1.000 P57759 →
Q60432 0.986 Q60432 →
Q2KIL5 0.985 Q2KIL5 →
A0A8M1N5Y4 0.982 A0A8M1N5Y4 →
Q5WA72 0.982 Q5WA72 →
HYOU1 Hypoxia up-regulated protein 1 0.982 landscape →
Q0JD42 0.981 Q0JD42 →
Q17688 0.981 Q17688 →
Q67IX6 0.981 Q67IX6 →
Q53LQ0 0.981 Q53LQ0 →
P38657 0.980 P38657 →
Q921X9 0.980 Q921X9 →
PDIA4 Protein disulfide-isomerase A4 0.980 landscape →
Q4VIT4 0.980 Q4VIT4 →
Q9CXI5 0.979 Q9CXI5 →
O44342 0.979 O44342 →
PDIA5 Protein disulfide-isomerase A5 0.978 landscape →
P0C5H9 0.978 P0C5H9 →
P80513 0.978 P80513 →
TXNDC5 Thioredoxin domain-containing protein 5 0.978 landscape →
P80284 0.978 P80284 →
Q43116 0.977 Q43116 →
Q295V5 0.977 Q295V5 →
Q9FF55 0.977 Q9FF55 →
P11598 0.977 P11598 →
Q63617 0.977 Q63617 →
Q66GQ3 0.977 Q66GQ3 →